Natixis Advisors’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-25,294
| Closed | -$1.4M | – | 1695 |
|
|
2025
Q3 | $1.4M | Sell |
25,294
-171
| -0.7% | -$8.89K | ﹤0.01% | 1215 |
|
|
2025
Q2 | $1.1M | Sell |
25,465
-5,538
| -18% | -$214K | ﹤0.01% | 1273 |
|
|
2025
Q1 | $1.23M | Sell |
31,003
-531
| -2% | -$23.5K | ﹤0.01% | 1223 |
|
|
2024
Q4 | $1.28M | Buy |
31,534
+3,626
| +13% | +$151K | ﹤0.01% | 1229 |
|
|
2024
Q3 | $1.09M | Buy |
27,908
+1,751
| +7% | +$69.7K | ﹤0.01% | 1268 |
|
|
2024
Q2 | $1.14M | Sell |
26,157
-5,232
| -17% | -$253K | ﹤0.01% | 1209 |
|
|
2024
Q1 | $1.5M | Buy |
31,389
+8,819
| +39% | +$396K | ﹤0.01% | 1110 |
|
|
2023
Q4 | $1.06M | Sell |
22,570
-5,529
| -20% | -$230K | ﹤0.01% | 1187 |
|
|
2023
Q3 | $1.34M | Buy |
28,099
+14,881
| +113% | +$812K | ﹤0.01% | 1096 |
|
|
2023
Q2 | $769K | Sell |
13,218
-22,983
| -63% | -$1.38M | ﹤0.01% | 1229 |
|
|
2023
Q1 | $2.59M | Buy |
36,201
+3,589
| +11% | +$285K | 0.01% | 873 |
|
|
2022
Q4 | $2.3M | Buy |
32,612
+4,478
| +16% | +$316K | 0.01% | 900 |
|
|
2022
Q3 | $1.71M | Buy |
+28,134
| New | +$1.89M | 0.01% | 941 |
|
|
2020
Q1 | – | Sell |
-19,977
| Closed | -$1.75M | – | 1209 |
|
|
2019
Q4 | $1.75M | Sell |
19,977
-21
| -0.1% | -$1.84K | 0.01% | 839 |
|
|
2019
Q3 | $1.7M | Sell |
19,998
-4,441
| -18% | -$396K | 0.01% | 815 |
|
|
2019
Q2 | $2.57M | Sell |
24,439
-1,011
| -4% | -$102K | 0.02% | 698 |
|
|
2019
Q1 | $2.69M | Sell |
25,450
-1,083
| -4% | -$109K | 0.02% | 661 |
|
|
2018
Q4 | $2.22M | Sell |
26,533
-14,363
| -35% | -$1.3M | 0.02% | 678 |
|
|
2018
Q3 | $4.17M | Sell |
40,896
-6,756
| -14% | -$652K | 0.04% | 544 |
|
|
2018
Q2 | $3.85M | Sell |
47,652
-2,610
| -5% | -$207K | 0.04% | 559 |
|
|
2018
Q1 | $3.7M | Buy |
50,262
+29,243
| +139% | +$2.19M | 0.04% | 545 |
|
|
2017
Q4 | $1.48M | Sell |
21,019
-45,777
| -69% | -$3.3M | 0.02% | 788 |
|
|
2017
Q3 | $4.17M | Buy |
66,796
+12,580
| +23% | +$745K | 0.04% | 487 |
|
|
2017
Q2 | $3.11M | Buy |
54,216
+7,875
| +17% | +$463K | 0.03% | 580 |
|
|
2017
Q1 | $2.82M | Buy |
46,341
+11,112
| +32% | +$629K | 0.03% | 608 |
|
|
2016
Q4 | $1.93M | Sell |
35,229
-1,833
| -5% | -$87.9K | 0.02% | 681 |
|
|
2016
Q3 | $1.71M | Sell |
37,062
-14,592
| -28% | -$616K | 0.02% | 684 |
|
|
2016
Q2 | $1.76M | Buy |
+51,654
| New | +$1.61M | 0.02% | 652 |
|
Other funds holding NGVT
SBH
RA
SCM
Natixis Advisors's NGVT Position: Q4 2025 in Review
Natixis Advisors sold out of Ingevity (NGVT) in Q4 2025, closing a stake of 25,294 shares — an estimated $1.4M sold.
Natixis Advisors first reported a position in NGVT in Q2 2016 and held it in 28 quarters. The position peaked at $4.17M in Q3 2017. 303 funds tracked by Wall St. Rank hold NGVT as of Q4 2025.
- Natixis Advisors reported no remaining Ingevity position as of Q4 2025 after selling out during the quarter.
- Natixis Advisors sold 25,294 Ingevity shares in Q4 2025, an estimated $1.4M.
- Natixis Advisors first reported a position in Ingevity in Q2 2016 and held it in 28 quarters.
- Natixis Advisors's Ingevity position peaked at $4.17M in Q3 2017.
- 303 funds tracked by Wall St. Rank held Ingevity as of Q4 2025.
Based on Natixis Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.